Diversa and Medarex Agree to Co-Develop Antibodies

Oct 17, 2003

NEW YORK, Oct. 17 (GenomeWeb News) - San Diego-based Diversa and Princeton, NJ-based Medarex yesterday announced they have entered into an R&D collaboration to develop and optimize antibodies to be used as drug targets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Re-Think on Science Standards

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Faster Efforts

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

Graves Wins Top Australian Science Prize

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

This Week in Cell

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.

Main menu